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Introduction.– Several neuromuscular reference centers collaborative work
(Reims, Créteil, Lille, Angers, Nantes, Nancy, Paris, Garches, Nice) allowed to
develop a new tool for specific measures reported by neuromuscular disease
persons.
Patients andmethods.–A first qualitative stage has building a bank of items with
five focuses groups among various functional patient stages of the disease
(n = 41) then a study of acceptance and feasibility of items (n = 56). The second
phase (n = 127) builded the structure and calibrate the metrics of the
questionnaire Qol-NMDv1.0 (factorial analysis and Item Response Theory).
Results.– The factorial analysis and data application in a item response theory
(n = 127) construct a questionnaire v1.0 with three dimensions.
Discussion.– Qol-NMD have to measure specific reported outcome from NMD
patient. Qol-NMD V1.0 is now structured and allows the calculation of a
research score (IRT method) or a clinical one (factorial analysis). Qol-NMD
scale consists of 26 items grouped in three domains: physical symptom impacts
(nine items), self perception (eight items), activities and participation (nine
items). An optional domain for the ventilated persons requires additional
inclusions before a consolidation of its structure and its metrics.
Conclusion.– This new tool Qol-NMDV1.0 will be compared with French
InoQol version and pursues its final psychometric validation with a new NMD
persons sample: phase III of the project.
http://dx.doi.org/10.1016/j.rehab.2013.07.530
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Introduction.– Interventions in Physical Medicine are global care. Quality of
life is a subjective point of view of the patient. Its measure is complex, but useful
to personalize the intervention and to evaluate the effect of our care. Among the
generic scales, the SF-36 showed good psychometric properties with
neuromuscular patients. However, Bank et al. described a not suitable structure
of composites scores, and Boyer et al. a ceiling effect in physical dimensions.
Finally, anxiety and depression are not studied in this scale. The aim of our
study was to determine the psychometrics properties of the Duke Health Profile
(DHP), chosen for its acceptability and its specifics dimensions of anxiety and
depression, in patients with slowly progressive neuromuscular disease.
Patients and methods.– successive inclusion of neuromuscular patients in
centers of Reims, Dijon and Besançon between April 2004 and June 2011. DHP
administration on two occasions, 15 days apart. Collection of socio-
demographics data. Statistical analyzes using SAS Software 9.3.
Results.– One hundred and thirty-nine patients were included. The acceptability
of DHP is excellent with a fill rate close to 100%. Disability dimension showed
an important ceiling effect. Reliability was good with a correct internal
consistency (Cronbach = 0.54–0.73), except for the social health dimension
(0.40) and good reproducibility (ICC = 0.55–0.83). Anxiety and depression
dimensions have discriminant properties to separate patients with a Barthel
index less or greater than 40.
Discussion.– DHP is suitable and valid for patients with neuromuscular disease,
with some reserve for the social health and disability dimensions. Dimensions
of anxiety and depression have a particular interest. A comparison with the
HADS scale should be interesting.
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Aims.– When rehabilitation is proposed for a long time to improve balance in
patients with mixed motor and sensory neuropathy, no study was performed to
characterize balance and gait in sensory neuropathy and their changes following
a specific training program.
Patients and method.– A rehabilitation program including foot sensory
stimulation, balance and gait training with limited vision was followed by 30
patients with ataxic neuropathy in order to stimulate multi-sensory compensa-
tion in a no-controlled and no-blinded study. Ataxic neuropathy was graded by a
pallesthetic score. The evaluation of patients and healthy subjects was
performed with clinical tests (Berg Balance Scale, Functional Reach Test and
Timed up and Go test) and instrumental tests for balance (force platform) and
gait (Locometre).
Results.– All patients exhibited impairments in balance and gait parameters
compared to control group values. A high pallesthetic score correlated with
increased sway area when standing with the eyes open on a firm surface. At the
end of the training program, significant changes were observed in balance
control assessed using the three clinical tests (Wilcoxon test, P < 0.001). A
tendency towards a reduction of the Romberg sign was noticed and limited
changes were observed after training in instrumental tests for balance and for
gait parameters. Age induced some limitations in balance and gait parameters
but had no effect on training results.
Discussion.– These results show that ataxic patients are impaired in balance and
gait but can improve clinical balance parameters following training with a
multisensory approach. We observed only limited correlations between the
pallesthetic score and some balance parameters, suggesting that various levels
of compensation occur in these patients. It confirms that balance and gait
training have to be recommended in the non-pharmacologic approach of ataxic
neuropathy with a positive short-term effect on dynamic balance parameters
without limitation due to age or degree of sensory impairment. The
effectiveness of this training program has to be evaluated in the future in a
controlled study to ascertain the contribution of the placebo effect in these
data.
Further reading
Missaoui B, Thoumie P. Gait and Posture (2013) in press.
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Objectives.– The aim of this study is to evaluate the benefits of a rehabilitation
program in terms of balance, gait and muscle strength in a population of patients
with fascioscapulohumeral muscular dystrophy.
Patients, material and method.– It is a retrospective analysis of a cross-section
of patients with FSHD. The patients received a rehabilitation program in the
outpatient unit (Rothschild hospital, Paris, France) between 2010 and 2013.
Each patient benefited of 20 sessions alternating two and three half-day per
week, with physiotherapy (muscle building, balance with unstable platform,
endurance), hydrotherapy and occupation therapy. A clinical and instrumental
evaluation was systematically proposed before and after the program. Balance
was clinically assessed using three scales (BBS, FRT, and TUG) and
instrumentally evaluated using a stabilometer. Gait parameters were analyzed
with the Locometre1, the muscle strength was quantified on an isokinetic
dynamometer at the speed of 608/s.
Results.– Twenty-four patients (nine women and 15 men aged 21 to 70 years) were
included in this study. After the rehabilitation program, there was a significant
balance improvement validated by clinical tests: BBS (51.7 to 54.3P = 0.001),FRT
(17.9 to 24.7 cm P < 0.0001), TUG (9.58 to 7.91 s P < 0.0001), an improvement
of the spontaneous gait speed (3.14 to 3.43 km/h P = 0.015) and of the muscle
strength (Q min +29.7%, HM min +28.8% and HM max +6%, P < 0.05).
No gain was observed for the stabilometric parameters, the fast gait speed and
the quadriceps of the stronger limb.
Discussion.– Intensive rehabilitation in patients suffering from fascioscapu-
lohumeral muscular dystrophy improves their balance abilities, muscle strength
and spontaneous gait speed. The long-term vision of this study would be to
evaluate the maintenance on middle run of the achieved capabilities and the
efficacy of the rehabilitation on the frequency of falls.
http://dx.doi.org/10.1016/j.rehab.2013.07.533
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Objective.– To determinate the safety and efficiency of intravenous immunoglo-
bulin treatment in post-polio syndrome, by the mean of an open clinical trial.
Patients.– A total of eleven patients, six men and five women, mean age 61 years
(range 43–72 years), with established post-polio syndrome diagnosis according to
Halstead and Rossi, were included in the study between July 2009 and December
2012.
Methods.– All patients received intravenous immunoglobulin, tegeline 0,4 mg/
kg per day, during five consecutive days every month for three to four months.
Pain measured by visual analogue scale, muscle strength measured by manual
testing and by quadriceps and hamstrings peak-torque using Con-Trex
dynamometer, and walking performance analyzed by means of 6-minute-
walk-test and 10-meters-walk speed, were noted before and after treatment.
Results.– Eight patients (73%) improved significantly all parameters, two
patients (18%) felt an improvement without modification of clinical tests, and
two (18%) had no change at all. The latter were the only patients who presented
without any pain. One of them reported side effects with headaches, nausea and
transient cutaneous eruption.
Discussion.– These data show that intravenous immunoglobulin seems to be a
safe and efficient treatment of post-polio syndrome, especially when pain is one
of the major symptoms [1]. Since a placebo effect cannot be excluded, a larger
controlled randomized double blinded study is needed to confirm these
preliminary results.
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Aim.– To analyse the gait of patients suffering from myotonic dystrophia
(Steinert) from a space-time and kinematic point of view.
Materials.– The gait analysis was carried out by using a video camera recorder
(Sony1), an optoelectronic system allowing 3D movement reconstruction
(Vicon1 + Worstation1 + Bodybuider1) and a Clinical Gait Analysis software
(Polygon1).
Patients.– Six patients (three women and three men) suffering from type-1
myotonic dystrophy followed in the tertiary neuromuscular diseases center
Reims University center (Champagne Ardenne, France) » and six healthy
women (three women and three men).
Methods.– All participants were asked to walk over 6 m at a spontaneous speed
meanwhile both space-time (speed, frequency, step length) and kinematic (3D
of hip, knee and ankle) parameters were recorded for further computations and
analyses. Both patients gait kinematics and space-time parameters were
compared to these of the healthy population.
Results.– As regards space-time parameters, the step frequency was higher and
the step length and speed were lower in patients compared to healthy population
which served as a standard reference (P < 0.05). As regards kinematic data, a
decrease of the pelvis forward tilting for both inclination and rotation
(P < 0.05); an increase in hip extension and abduction, an increase in ankle
flexion/extension and increase in foot rotation were reported.
Discussion.– The space-time observations highlight results that are more likely to
be related to falling risks. Kinematic analysis clearly showed muscular
insufficiencies which are responsible of abnormal locomotion, that is; either an
increased hip abduction/adduction angles highlighting hip stabilization insuffi-
ciency, or an increased hip extension highlighting a deteriorated posterior step [1,2].
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